Ncardia and Cellistic Appoint Charles Jacques as CFO
FDA Gene Therapy Approval for Duchenne Muscular Dystrophy
iPSCs in Drug Discovery: Regulatory Shifts and Animal Models
FDA Modernization Act 2.0: Animal Testing No Longer Mandatory
.png)
Ncardia and Cellistic Appoint Gustavo Mahler to Lead Growth
Press release: Ncardia launches Cellistic, an iPSC cell therapy CDMO
Subscribe to our newsletter
Stay up to date on iPSC innovations, events and news.
